Compare GeneDx Holdings Corp (WGS) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs 22nd Century Group Inc — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: GeneDx Holdings Corp is far larger — about 1208.1× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| WGS | XXII | |
|---|---|---|
Market Cap | $1.80B | $1.49M |
Sector | Technology | Technology |
52-Week High | $167.51 | $1.07K |
52-Week Low | $34.51 | $3.90 |
Enterprise Value | $1.80B | -$6.74M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
